Topiramate and Bradyphrenia - a phase IV clinical study of FDA data

Summary:

Bradyphrenia is found among people who take Topiramate, especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Topiramate and have Bradyphrenia. It is created by eHealthMe based on reports of 39,034 people who have side effects when taking Topiramate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 28, 2022

39,034 people reported to have side effects when taking Topiramate.
Among them, 133 people (0.34%) have Bradyphrenia.

What is Topiramate?

Topiramate has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 40,558 Topiramate users for its effectiveness, alternative drugs and more.

What is Bradyphrenia?

Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain) is found to be associated with 988 drugs and 661 conditions by eHealthMe.

Number of Topiramate and Bradyphrenia reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Topiramate and have Bradyphrenia?

Check whether Bradyphrenia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

Related studies

How severe was Bradyphrenia and when was it recovered:

Bradyphrenia in Topiramate

Expand to all the drugs that have ingredients of topiramate:

Bradyphrenia and drugs with ingredients of topiramate (139 reports)

Alternative drugs to, pros and cons of Topiramate:

Topiramate (40,558 reports)

Common Topiramate side effects:

Drug ineffective: 4,046 reports
Headache (pain in head): 2,566 reports
Fatigue (feeling of tiredness): 2,428 reports
Dizziness: 1,720 reports
Migraine (headache): 1,644 reports
Pain: 1,627 reports
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1,516 reports
Drowsiness: 1,501 reports

Browse all side effects of Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Bradyphrenia treatments and more:

Bradyphrenia (6,808 reports)

COVID vaccines that are related to Bradyphrenia:

Common drugs associated with Bradyphrenia:

All the drugs that are associated with Bradyphrenia:

Bradyphrenia (988 drugs)

Common conditions associated with Bradyphrenia:

All the conditions that are associated with Bradyphrenia:

Bradyphrenia (661 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on topiramate (the active ingredients of Topiramate) and Topiramate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.